Humar, Abhinav

Publications

Impact Factor

Cites

Reference	Impact Factor	Cites	Quartile
Thomson AW, Humar A, Lakkis FG, Metes DM. Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies. Hum Immunol. 2018 May;79(5):314-321. doi: 10.1016/j.humimm.2017.10.017. Epub 2017 Oct 31. Review. PubMed PMID: 29100944; PubMed Central PMCID: PMC5924712.	2.412	46	3
Macedo C, Tran L, Zahorchak AF, Dai H, Gu X, Ravichandran R, Mohanakumar T, Elinoff B, Zeevi A, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients. Am J Transplant. 2020 Nov 10. doi: 10.1111/ajt.16393. [Epub ahead of print] PubMed PMID: 33171019.	7.338	26	1
Tran L, Humar A. Tolerance studies in liver transplantation: are we fooling ourselves? Curr Opin Organ Transplant. 2020 Apr;25(2):151-157. doi: 10.1097/MOT.0000000000000738. PubMed PMID: 32073482.	2.571	8	3
Zahorchak AF, DeRiggi ML, Muzzio JL, Sutherland V, Humar A, Lakkis FG, Hsu YS, Thomson AW. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients. Cytotherapy. 2023 Jan 11:S1465-3249(22)01026-X. doi: 10.1016/j.jcyt.2022.11.005. Online ahead of print. PubMed PMID: 36639251.	6.196	2
Tran LM, Macedo C, Zahorchak AF, Gu X, Elinoff B, Singhi AD, Isett B, Zeevi A, Sykes M, Breen K, Srivastava A, Ables EM, Landsittel D, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion modulates effector CD8+ T cell and NK cell responses after liver transplantation. Sci Transl Med. 2023 Oct 11;15(717):eadf4287. doi: 10.1126/scitranslmed.adf4287. Epub 2023 Oct 11. PubMed PMID: 37820009.	17.1	0
Harinstein ME, Gandolfo C, Gruttadauria S, Accardo C, Crespo G, VanWagner LB, Humar A. Cardiovascular disease assessment and management in liver transplantation. Eur Heart J. 2024 Aug 17:ehae502. doi: 10.1093/eurheartj/ehae502. Online ahead of print. PubMed PMID: 39152050.	37.6
Humar A, Hadjiyannis Y, Macedo C, Tran LM, Elinoff BD, Hughes CB, Ganesh SR, Zahorchak AF, Ables EM, Styn MA, Landsittel D, Zeevi A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial. Nat Commun. 2026 Apr 17;17(1):3226. doi: 10.1038/s41467-026-71280-8. PubMed PMID: 41997912; PubMed Central PMCID: PMC13090339.	15.7
Humar A, Hadjiyannis Y, Macedo C, Tran LM, Elinoff BD, Hughes CB, Ganesh SR, Zahorchak AF, Ables EM, Styn MA, Landsittel D, Zeevi A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial. Nat Commun. 2026 Apr 17;17(1):3226. doi: 10.1038/s41467-026-71280-8. PubMed PMID: 41997912; PubMed Central PMCID: PMC13090339.	15.7
Macedo C, Hadjiyannis Y, Tran LM, Elinoff BD, Abukhiran IM, Singhi AD, Isett B, Breen K, Zahorchak AF, Ables EM, Liu JJ, Liu S, Sykes M, Zeevi A, Landsittel D, Lakkis FG, Humar A, Metes DM, Thomson AW. Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Sci Transl Med. 2026 Aug 5;18(861):eaec4107. doi: 10.1126/scitranslmed.aec4107. Epub 2026 Aug 5. PubMed PMID: 42555758.	14.6
Tanimine N, Markmann JF, Wood-Trageser MA, Demetris AJ, Mason K, Silva JAF, Levitsky J, Feng S, Humar A, Emond JC, Shaked A, Klintmalm G, Sanchez-Fueyo A, Lesniak D, Breeden CP, Nepom GT, Bridges ND, Goldstein J, Larsen CP, DesMarais M, Gaile G, Chandran S. Donor-specific Immune Senescence as a Candidate Biomarker of Operational Tolerance Following Liver Transplantation in Adults: Results of a Prospective, Multicenter Cohort Study. Am J Transplant. 2024 Nov 4:S1600-6135(24)00682-8. doi: 10.1016/j.ajt.2024.10.022. Online ahead of print. PubMed PMID: 39505152.	8.9

Reference

Impact Factor

Cites

Quartile

Thomson AW, Humar A, Lakkis FG, Metes DM. Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies. Hum Immunol. 2018 May;79(5):314-321. doi: 10.1016/j.humimm.2017.10.017. Epub 2017 Oct 31. Review. PubMed PMID: 29100944; PubMed Central PMCID: PMC5924712.

2.412

Macedo C, Tran L, Zahorchak AF, Dai H, Gu X, Ravichandran R, Mohanakumar T, Elinoff B, Zeevi A, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients. Am J Transplant. 2020 Nov 10. doi: 10.1111/ajt.16393. [Epub ahead of print] PubMed PMID: 33171019.

7.338

Tran L, Humar A. Tolerance studies in liver transplantation: are we fooling ourselves? Curr Opin Organ Transplant. 2020 Apr;25(2):151-157. doi: 10.1097/MOT.0000000000000738. PubMed PMID: 32073482.

2.571

Zahorchak AF, DeRiggi ML, Muzzio JL, Sutherland V, Humar A, Lakkis FG, Hsu YS, Thomson AW. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients. Cytotherapy. 2023 Jan 11:S1465-3249(22)01026-X. doi: 10.1016/j.jcyt.2022.11.005. Online ahead of print. PubMed PMID: 36639251.

6.196

Tran LM, Macedo C, Zahorchak AF, Gu X, Elinoff B, Singhi AD, Isett B, Zeevi A, Sykes M, Breen K, Srivastava A, Ables EM, Landsittel D, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion modulates effector CD8+ T cell and NK cell responses after liver transplantation. Sci Transl Med. 2023 Oct 11;15(717):eadf4287. doi: 10.1126/scitranslmed.adf4287. Epub 2023 Oct 11. PubMed PMID: 37820009.

17.1

Harinstein ME, Gandolfo C, Gruttadauria S, Accardo C, Crespo G, VanWagner LB, Humar A. Cardiovascular disease assessment and management in liver transplantation. Eur Heart J. 2024 Aug 17:ehae502. doi: 10.1093/eurheartj/ehae502. Online ahead of print. PubMed PMID: 39152050.

37.6

Humar A, Hadjiyannis Y, Macedo C, Tran LM, Elinoff BD, Hughes CB, Ganesh SR, Zahorchak AF, Ables EM, Styn MA, Landsittel D, Zeevi A, Lakkis FG, Metes DM, Thomson AW. Donor-derived regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in living-donor liver transplantation: a phase I/IIa trial. Nat Commun. 2026 Apr 17;17(1):3226. doi: 10.1038/s41467-026-71280-8. PubMed PMID: 41997912; PubMed Central PMCID: PMC13090339.

15.7

Macedo C, Hadjiyannis Y, Tran LM, Elinoff BD, Abukhiran IM, Singhi AD, Isett B, Breen K, Zahorchak AF, Ables EM, Liu JJ, Liu S, Sykes M, Zeevi A, Landsittel D, Lakkis FG, Humar A, Metes DM, Thomson AW. Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Sci Transl Med. 2026 Aug 5;18(861):eaec4107. doi: 10.1126/scitranslmed.aec4107. Epub 2026 Aug 5. PubMed PMID: 42555758.

14.6

Tanimine N, Markmann JF, Wood-Trageser MA, Demetris AJ, Mason K, Silva JAF, Levitsky J, Feng S, Humar A, Emond JC, Shaked A, Klintmalm G, Sanchez-Fueyo A, Lesniak D, Breeden CP, Nepom GT, Bridges ND, Goldstein J, Larsen CP, DesMarais M, Gaile G, Chandran S. Donor-specific Immune Senescence as a Candidate Biomarker of Operational Tolerance Following Liver Transplantation in Adults: Results of a Prospective, Multicenter Cohort Study. Am J Transplant. 2024 Nov 4:S1600-6135(24)00682-8. doi: 10.1016/j.ajt.2024.10.022. Online ahead of print. PubMed PMID: 39505152.

8.9

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain